We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+42.64%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$1.46B
AUM Growth
+$256M
Cap. Flow
+$4.95B
Cap. Flow %
338.44%
Top 10 Hldgs %
14.04%
Holding
1,230
New
412
Increased
195
Reduced
230
Closed
293

Sector Composition

Rank Sector Weight
1 Technology 11.56%
2 Consumer Discretionary 8.68%
3 Healthcare 7.6%
4 Communication Services 6.73%
5 Industrials 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADV icon
251
Advantage Solutions
ADV
$540M
$1.54M 0.11%
+5,340
New +$1.43M
DISH
252
DELISTED
DISH Network Corp.
DISH
$1.52M 0.1%
44,001
-3,910
-8% -$109K
BIDU icon
253
Baidu
BIDU
$38.4B
$1.51M 0.1%
12,639
+6,750
+115% +$722K
KALV
254
DELISTED
KalVista Pharmaceuticals
KALV
$1.51M 0.1%
124,902
+16,410
+15% +$175K
SAQNW
255
DELISTED
Software Acquisition Group Inc. Warrant
SAQNW
$1.51M 0.1%
150,000
UAA icon
256
Under Armour
UAA
$2.92B
$1.5M 0.1%
+154,487
New +$1.47M
BRLIU
257
DELISTED
Brilliant Acquisition Corporation Unit
BRLIU
$1.5M 0.1%
+150,000
New +$1.51M
CPAY icon
258
Corpay
CPAY
$25.1B
$1.5M 0.1%
5,956
+614
+11% +$146K
ZGNX
259
DELISTED
Zogenix, Inc.
ZGNX
$1.5M 0.1%
+55,471
New +$1.53M
AER icon
260
AerCap
AER
$24.1B
$1.49M 0.1%
48,436
+32,722
+208% +$935K
IPV.WS
261
DELISTED
InterPrivate Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for shares of com
IPV.WS
$1.49M 0.1%
150,000
ITCI
262
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.48M 0.1%
+577
New +$11.7K
CLF icon
263
PUT
Cleveland-Cliffs
CLF
$6.39B
$1.48M 0.1%
2,672
+607
+29% +$2.95K
NLY icon
264
Annaly Capital Management
NLY
$17.1B
$1.46M 0.1%
+55,806
New +$1.38M
PPD
265
DELISTED
PPD, Inc. Common Stock
PPD
$1.46M 0.1%
54,428
+3,016
+6% +$75.4K
ORCL icon
266
CALL
Oracle
ORCL
$403B
$1.45M 0.1%
+263
New +$13.9K
LILAK icon
267
Liberty Latin America Class C
LILAK
$1.66B
$1.45M 0.1%
178,932
+155,576
+666% +$1.32M
SBBP
268
DELISTED
Strongbridge Biopharma plc.
SBBP
$1.45M 0.1%
382,400
-5,909
-2% -$17.7K
DAY
269
DELISTED
Dayforce
DAY
$1.44M 0.1%
+18,200
New +$1.17M
BZUN
270
Baozun
BZUN
$172M
$1.44M 0.1%
+37,500
New +$1.18M
BYD icon
271
Boyd Gaming
BYD
$6.12B
$1.44M 0.1%
68,724
+26,944
+64% +$491K
CRBP icon
272
PUT
Corbus Pharmaceuticals
CRBP
$165M
$1.43M 0.1%
+57
New +$11.5K
BIIB icon
273
Biogen
BIIB
$29.7B
$1.42M 0.1%
5,313
-906
-15% -$272K
MPT
274
PUT
Medical Properties Trust
MPT
$2.75B
$1.42M 0.1%
+756
New +$13.4K
VMM
275
DELISTED
Delaware Investments Minnesota Municipal Income Fund II
VMM
$1.41M 0.1%
111,592

Similar funds

Boothbay Fund Management's Q2 2020 Portfolio in Review

As of Q2 2020, Boothbay Fund Management held 1,230 positions worth $1.46B, up 21% from $1.21B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Boothbay Fund Management deployed $4.95B of net new capital in Q2 2020, opening 412 new positions and adding to 195 existing holdings. Its largest new stake was Tesla: 90,556,950 shares worth $25.6M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Sprott Physical Platinum and Palladium Trust, an estimated $11.4M trimmed.

  • Boothbay Fund Management's largest Q2 2020 buy was Tesla: 90,556,950 shares worth $25.6M.
  • Boothbay Fund Management added most to Alphabet (Google) Class C in Q2 2020, an estimated $27.1M increase.
  • Boothbay Fund Management's biggest Q2 2020 reduction was Sprott Physical Platinum and Palladium Trust, cutting an estimated $11.4M.
  • Boothbay Fund Management fully exited Allergan plc in Q2 2020, selling an estimated $46.4M.
  • Boothbay Fund Management's ten largest holdings make up 14% of its $1.46B portfolio in Q2 2020.
  • Boothbay Fund Management opened 412 new positions and closed 293 in Q2 2020.
  • Boothbay Fund Management's portfolio value rose 21% quarter-over-quarter to $1.46B.

Based on Boothbay Fund Management's 13F filing for Q2 2020, filed 14 Aug 2020.